Subscribe to GlobalData Explorer to access actionable intelligence spanning 22 industries, 200+ economies and 700k+ companies on a single platform

Number of ongoing Clinical Trials (for drugs) involving Chordoma by Phase

  • There are currently 34 ongoing clinical trials involving Chordoma

  • Of the 34 trials,18 trials are in Phase II

  • Furthermore, 7 trials are in Phase I/II

Number of ongoing Clinical Trials (for drugs) involving Chordoma by Phase

Published: October 2021
Source: GlobalData

The global pharmaceutical industry is steadily developing new drugs for Chordoma, an Oncology indication. The largest number of ongoing clinical trials for Chordoma is conducted in North America. Europe and Asia-Pacific are among some of the other prominent regions involved in Chordoma-related drug trials.

National Cancer Institute US: The leading ongoing Chordoma-related clinical trials sponsor

National Cancer Institute US, the US-based government agency, is the top sponsor for Chordoma-related ongoing clinical trials.

Epizyme Inc, Shanghai Changzheng Hospital, Centre Leon Berard, UNICANCER Group, and John Wayne Cancer Institute are a few other notable sponsors involving Chordoma. A clinical trial sponsor can be a Company, Government, Individual, or Institution.

Explore, track and compare industries, economies and companies in a single platform through GlobalData Explorer.​

Single License $700 per month (billed Annually)
Multiple Licenses Connect with a GlobalData representative to discover our offers for multiple licenses​
  • 700K+Companies
  • 22Industries
  • 15K+Reports
  • 200+Countries & Regions
Still looking?

Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.


Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company Analytics

Contact the team or request a demo to find out how our data can drive your business forward